Connect with us

Technology

Veeva Announces Fiscal 2027 First Quarter Results

Published

on

Total Revenues of $882.9M, up 16% Year Over Year
Subscription Revenues of $730.2M, up 15% Year Over Year

PLEASANTON, Calif., June 3, 2026 /PRNewswire/ — Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2026.

“Our rapid progress with Veeva AI sets the foundation as we enter the next chapter of our industry cloud,” said CEO Peter Gassner. “We are moving from an industry-specific application company to an industry-specific application and AI agent company. This is a major transformation for Veeva and the industry that will help our customers bring the right medicines to patients faster.”

Fiscal 2027 First Quarter Results:

Revenues: Total revenues for the first quarter were $882.9 million, up from $759.0 million one year ago, an increase of 16% year over year. Subscription revenues for the first quarter were $730.2 million, up from $634.8 million one year ago, an increase of 15% year over year.

Operating Income and Non-GAAP Operating Income:(1) First quarter operating income was $273.1 million, compared to $233.7 million one year ago, an increase of 17% year over year. Non-GAAP operating income for the first quarter was $395.4 million, compared to $349.9 million one year ago, an increase of 13% year over year.

Net Income and Non-GAAP Net Income:(1) First quarter net income was $260.9 million, compared to $228.2 million one year ago, an increase of 14% year over year. Non-GAAP net income for the first quarter was $371.1 million, compared to $327.8 million one year ago, an increase of 13% year over year.

Net Income per Share and Non-GAAP Net Income per Share:(1) For the first quarter, fully diluted net income per share was $1.57, compared to $1.37 one year ago, while non-GAAP fully diluted net income per share was $2.24, compared to $1.97 one year ago.

“Our first quarter results exceeded guidance on all metrics, reflecting another quarter of broad-based growth and profitability,” said CFO Brian Van Wagener. “We’re pleased with the raised fiscal 2027 guidance and energized by the large and growing opportunity ahead.”

Recent Highlights:

Advancing Industry AI with Rapid Progress Across Veeva AI – Veeva significantly advanced its industry AI strategy this quarter. Ostro, acquired in March, is delivering compliant, conversational AI for more than 50 brands. Vault AI is on track to expand to all Vault applications in August. Veeva Falcon, the new platform delivering agentic labor for clinical, regulatory, and safety, is planned for early adopter release in November.Leading the Industry with Agentic Commercial – At Commercial Summit in May, Veeva shared its vision for Agentic Commercial, leveraging AI to help biopharmas bring the right medicines to more patients. With capabilities like the Agentic Call Report in Vault CRM and Ostro’s conversational AI on brand websites, biopharmas can now generate and act on Commercial Evidence. In Vault CRM, the industry’s fastest path to Agentic CRM success, Veeva added 27 new Vault CRM customers in the quarter and now has more than 150 customers live.Bringing Agentic Labor to Veeva Development Cloud – Veeva expanded its leadership with multiple enterprise biopharma wins across clinical, regulatory, and safety. Additionally, Veeva showcased its AI strategy at the recent European R&D and Quality Summit in Copenhagen, generating strong customer interest in Vault AI and Veeva Falcon to drive productivity and speed in drug development.

Financial Outlook:

Veeva is providing guidance for its fiscal second quarter ending July 31, 2026 as follows:

Total revenues between $902 and $905 million.Non-GAAP operating income between $392 and $395 million.(2)Non-GAAP fully diluted net income per share between $2.21 and $2.22.(2)

Veeva is providing updated guidance for its fiscal year ending January 31, 2027 as follows:

Total revenues between $3,635 and $3,645 million.Non-GAAP operating income of about $1,610 million.(2)Non-GAAP fully diluted net income per share of approximately $9.05.(2)

Conference Call Information

Prepared remarks and an investor presentation providing additional information and analysis can be found on Veeva’s investor relations website at ir.veeva.com. Veeva will host a Q&A conference call at 2:00 p.m. PT today, June 3, 2026, and a replay of the call will be available on Veeva’s investor relations website.

What:

Veeva Systems Fiscal 2027 First Quarter Results Conference Call

When:

Wednesday, June 3, 2026

Time:

2:00 p.m. PT (5:00 p.m. ET)

Online Registration:

https://events.q4inc.com/analyst/423437130?pwd=ckfYa8Xa 

Webcast:

ir.veeva.com

___________

(1) This press release uses non-GAAP financial metrics that are adjusted for the impact of various GAAP items. See the section titled “Non-GAAP Financial Measures” and the tables entitled “Reconciliation of GAAP to Non-GAAP Financial Measures” below for details.

(2) Veeva is not able, at this time, to provide GAAP targets for operating income and fully diluted net income per share for the second fiscal quarter ending July 31, 2026 or the fiscal year ending January 31, 2027 because of the difficulty of estimating certain items excluded from non-GAAP operating income and non-GAAP fully diluted net income per share that cannot be reasonably predicted, such as charges related to stock-based compensation expense. The effect of these excluded items may be significant.

About Veeva Systems

Veeva delivers the industry cloud for life sciences with cloud software, AI, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings, and public conference calls and webcasts.

Forward-looking Statements

This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotes from management and guidance, provided as of June 3, 2026, about Veeva’s expected future financial results. Estimating guidance accurately for future periods is difficult. It involves assumptions and internal estimates that may prove to be incorrect and is based on plans that may change. Hence, there is a significant risk that actual results could differ materially from the guidance we have provided in this release and we have no obligation to update such guidance. There are also numerous risks that have the potential to negatively impact our financial performance, including issues related to the performance, availability, security, or privacy of our products, competitive factors, customer decisions and priorities, developments that impact the life sciences industry (including regulatory, funding, or policy changes), general macroeconomic and geopolitical events (including changes in trade policy or practices, inflationary pressures, currency exchange fluctuations, changes in interest rates, and geopolitical conflicts), and issues that impact our ability to hire, retain and adequately compensate talented employees. We have summarized what we believe are the principal risks to our business in a section titled “Summary of Risk Factors” on pages 13 and 14 in our filing on Form 10-K for the period ended January 31, 2026 which you can find here. Additional details on the risks and uncertainties that may impact our business can be found in the same filing on Form 10-K and in our subsequent SEC filings, which you can access at sec.gov. We recommend that you familiarize yourself with these risks and uncertainties before making an investment decision.

Investor Relations Contact:

Media Contact:

Gunnar Hansen

Maria Scurry

Veeva Systems Inc.

Veeva Systems Inc.

267-460-5839

781-366-7617

ir@veeva.com

pr@veeva.com

 

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

April 30,
2026

January 31,
2026

Assets

Current assets:

Cash and cash equivalents

$    1,896,580

$    1,421,233

Short-term investments

5,416,139

5,139,581

Accounts receivable, net

568,020

1,259,737

Unbilled accounts receivable

59,752

50,609

Prepaid expenses and other current assets

122,770

126,470

Total current assets

8,063,261

7,997,630

Property and equipment, net

73,484

70,261

Deferred costs, net

28,686

29,961

Lease right-of-use assets

82,060

75,626

Goodwill

488,161

439,877

Intangible assets, net

55,508

30,314

Deferred income taxes

272,665

273,417

Other long-term assets

65,733

62,257

Total assets

$    9,129,558

$    8,979,343

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$         40,657

$         37,644

Accrued compensation and benefits

52,572

45,857

Accrued expenses and other current liabilities

50,974

45,885

Income tax payable

67,897

6,698

Deferred revenue

1,476,539

1,488,819

Lease liabilities

13,131

12,153

Total current liabilities

1,701,770

1,637,056

Deferred income taxes

1,148

558

Long-term lease liabilities

89,936

83,706

Other long-term liabilities

32,350

43,271

Total liabilities

1,825,204

1,764,591

Stockholders’ equity:

Common stock

2

2

Additional paid-in capital

2,699,707

2,843,089

Accumulated other comprehensive (loss) income

(19,792)

8,160

Retained earnings

4,624,437

4,363,501

Total stockholders’ equity

7,304,354

7,214,752

Total liabilities and stockholders’ equity

$    9,129,558

$    8,979,343

 

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

 

Three months ended April 30,

2026

2025

Revenues:

Subscription(3)

$      730,175

$      634,768

Professional services and other(4)

152,773

124,275

Total revenues

882,948

759,043

Cost of revenues(5):

Cost of subscription

99,103

78,346

Cost of professional services and other

121,821

95,478

Total cost of revenues

220,924

173,824

Gross profit

662,024

585,219

Operating expenses(5):

Research and development

208,323

184,033

Sales and marketing

111,117

98,628

General and administrative

69,472

68,826

Total operating expenses

388,912

351,487

Operating income

273,112

233,732

Other income, net

74,418

65,089

Income before income taxes

347,530

298,821

Income tax provision

86,594

70,631

Net income

$      260,936

$      228,190

Net income per share:

Basic

$            1.60

$            1.40

Diluted

$            1.57

$            1.37

Weighted-average shares used to compute net income per share:

Basic

163,345

162,749

Diluted

165,989

166,229

Other comprehensive income:

Net change in unrealized (loss) gain on available-for-sale investments

$      (27,451)

$        17,367

Net change in cumulative foreign currency translation loss

(501)

(38)

Comprehensive income

$      232,984

$      245,519

(3) Includes subscription revenues from the following product areas:

Veeva Commercial Solutions

$      337,866

$      305,411

Veeva R&D and Quality Solutions

392,309

329,357

Total subscription

$      730,175

$      634,768

(4) Includes professional services and other revenues from the following product areas:

Veeva Commercial Solutions

$        57,573

$        46,567

Veeva R&D and Quality Solutions

95,200

77,708

Total professional services and other

$      152,773

$      124,275

(5) Includes stock-based compensation as follows:

Cost of revenues:

Cost of subscription

$          1,761

$          1,715

Cost of professional services and other

14,151

12,769

Research and development

51,563

47,949

Sales and marketing

24,594

22,321

General and administrative

27,190

27,456

Total stock-based compensation

$      119,259

$      112,210

 

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

Three months ended April 30,

2026

2025

Cash flows from operating activities

Net income

$      260,936

$      228,190

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

11,587

9,822

Reduction of lease right-of-use assets

3,279

3,265

Accretion of discount on short-term investments

(1,788)

(2,509)

Stock-based compensation

119,259

112,210

Amortization of deferred costs

4,900

4,043

Deferred income taxes

14,337

(27,418)

Other, net

(1,777)

4,327

Changes in operating assets and liabilities:

Accounts receivable

696,614

522,686

Unbilled accounts receivable

(9,143)

(7,672)

Deferred costs

(3,625)

(4,055)

Prepaid expenses and other current and long-term assets

(7,984)

(4,501)

Accounts payable

4,473

7,743

Accrued expenses and other current liabilities

8,923

(8,720)

Income tax payable

61,199

82,345

Deferred revenue

(32,963)

(41,361)

Lease liabilities

(2,460)

(2,543)

Other long-term liabilities

1,349

1,306

Net cash provided by operating activities

1,127,116

877,158

Cash flows from investing activities

Purchases of short-term investments

(982,315)

(667,100)

Maturities and sales of short-term investments

670,835

620,903

Long-term assets

(1,751)

(5,910)

Acquisitions, net of cash acquired

(75,480)

—

Net cash used in investing activities

(388,711)

(52,107)

Cash flows from financing activities

Proceeds from exercise of common stock options

2,939

40,605

Repurchases of common stock

(226,947)

—

Taxes paid related to net share settlement of equity awards

(38,518)

(20,225)

Net cash (used in) provided by financing activities

(262,526)

20,380

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(532)

766

Net change in cash, cash equivalents, and restricted cash

475,347

846,197

Cash, cash equivalents, and restricted cash at beginning of period

1,423,412

1,120,963

Cash, cash equivalents, and restricted cash at end of period

$   1,898,759

$   1,967,160

Supplemental disclosures of other cash flow information:

Excess tax (deficiency) benefit from employee stock plans

$         (4,092)

$          2,579

Non-GAAP Financial Measures

In Veeva’s public disclosures, Veeva has provided non-GAAP measures, which it defines as financial information that has not been prepared in accordance with generally accepted accounting principles in the United States, or GAAP. In addition to its GAAP measures, Veeva uses these non-GAAP financial measures internally for budgeting and resource allocation purposes and in analyzing its financial results. For the reasons set forth below, Veeva believes that excluding the following items provides information that is helpful in understanding its operating results, evaluating its future prospects, comparing its financial results across accounting periods, and comparing its financial results to its peers, many of which provide similar non-GAAP financial measures.

Excess tax benefit (deficiency). Excess tax benefits (deficiencies) from employee stock plans are dependent on previously agreed-upon equity grants to our employees, vesting of those grants, stock price, and exercise behavior of our employees, which can fluctuate from quarter to quarter. Because these fluctuations are not directly related to our business operations, Veeva finds it useful to exclude excess tax benefits (deficiencies) when assessing the level of cash provided by operating activities. Given the nature of the excess tax benefits (deficiencies), Veeva believes excluding it allows investors to make meaningful comparisons between our operating cash flows from quarter to quarter and those of other companies.Stock-based compensation expenses. Veeva excludes stock-based compensation expenses primarily because they are non-cash expenses that Veeva excludes from its internal management reporting processes. Veeva’s management also finds it useful to exclude these expenses when they assess the appropriate level of various operating expenses and resource allocations when budgeting, planning and forecasting future periods. Moreover, because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use, Veeva believes excluding stock-based compensation expenses allows investors to make meaningful comparisons between our recurring core business operating results and those of other companies.Amortization of purchased intangibles. Veeva incurs amortization expense for purchased intangible assets in connection with acquisitions of certain businesses and technologies. Amortization of intangible assets is a non-cash expense and is inconsistent in amount and frequency because it is significantly affected by the timing, size of acquisitions and the inherent subjective nature of purchase price allocations. Because these costs have already been incurred and cannot be recovered, and are non-cash expenses, Veeva excludes these expenses for its internal management reporting processes. Veeva’s management also finds it useful to exclude these charges when assessing the appropriate level of various operating expenses and resource allocations when budgeting, planning and forecasting future periods. Investors should note that the use of intangible assets contributed to Veeva’s revenues earned during the periods presented and will contribute to Veeva’s future period revenues as well.Litigation settlement-related charges. We exclude certain costs related to litigation settlements, including outcome-based payments to the law firms that represented us, because they are non-recurring and outside the ordinary course of business. Because these costs are unrelated to our day-to-day business operations, we believe excluding them enables more consistent evaluation of our operating results.Income tax effects on the difference between GAAP and non-GAAP costs and expenses. The income tax effects that are excluded relate to the imputed tax impact on the difference between GAAP and non-GAAP costs and expenses due to stock-based compensation and purchased intangibles for GAAP and non-GAAP measures.

There are limitations to using non-GAAP financial measures because non-GAAP financial measures are not prepared in accordance with GAAP and may be different from non-GAAP financial measures provided by other companies. The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact upon our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by Veeva’s management about which items are adjusted to calculate its non-GAAP financial measures. Veeva compensates for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in its public disclosures.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Veeva encourages its investors and others to review its financial information in its entirety, not to rely on any single financial measure to evaluate its business, and to view its non-GAAP financial measures in conjunction with the most directly comparable GAAP financial measures. A reconciliation of GAAP to the non-GAAP financial measures has been provided in the tables below.

 

VEEVA SYSTEMS INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Dollars in thousands)

(Unaudited)

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

Reconciliation of Net Cash Provided by Operating Activities (GAAP basis to non-GAAP basis)

Three months ended April 30,

2026

2025

Net cash provided by operating activities on a GAAP basis

$ 1,127,116

$   877,158

Excess tax deficiency (benefit) from employee stock plans

4,092

(2,579)

Net cash provided by operating activities on a non-GAAP basis

$ 1,131,208

$   874,579

Net cash used in investing activities on a GAAP basis

$   (388,711)

$    (52,107)

Net cash (used in) provided by financing activities on a GAAP basis

$   (262,526)

$     20,380

Reconciliation of Financial Measures (GAAP basis to non-GAAP basis)

Three months ended April 30,

2026

2025

Cost of subscription revenues on a GAAP basis

$     99,103

$     78,346

Stock-based compensation expense

(1,761)

(1,715)

Amortization of purchased intangibles

(674)

(1,012)

Cost of subscription revenues on a non-GAAP basis

$     96,668

$     75,619

Gross margin on subscription revenues on a GAAP basis

86.4 %

87.7 %

Stock-based compensation expense

0.2

0.3

Amortization of purchased intangibles

0.2

0.1

Gross margin on subscription revenues on a non-GAAP basis

86.8 %

88.1 %

Cost of professional services and other revenues on a GAAP basis

$    121,821

$     95,478

Stock-based compensation expense

(14,151)

(12,769)

Amortization of purchased intangibles

—

(134)

Cost of professional services and other revenues on a non-GAAP basis

$    107,670

$     82,575

Gross margin on professional services and other revenues on a GAAP basis

20.3 %

23.2 %

Stock-based compensation expense

9.2

10.3

Amortization of purchased intangibles

—

0.1

Gross margin on professional services and other revenues on a non-GAAP basis

29.5 %

33.6 %

Gross profit on a GAAP basis

$    662,024

$    585,219

Stock-based compensation expense

15,912

14,484

Amortization of purchased intangibles

674

1,146

Gross profit on a non-GAAP basis

$    678,610

$    600,849

Gross margin on total revenues on a GAAP basis

75.0 %

77.1 %

Stock-based compensation expense

1.8

1.9

Amortization of purchased intangibles

0.1

0.2

Gross margin on total revenues on a non-GAAP basis

76.9 %

79.2 %

Research and development expense on a GAAP basis

$    208,323

$    184,033

Stock-based compensation expense

(51,563)

(47,949)

Research and development expense on a non-GAAP basis

$    156,760

$    136,084

Three months ended April 30,

2026

2025

Sales and marketing expense on a GAAP basis

$    111,117

$     98,628

Stock-based compensation expense

(24,594)

(22,321)

Amortization of purchased intangibles

(2,331)

(2,795)

Sales and marketing expense on a non-GAAP basis

$     84,192

$     73,512

General and administrative expense on a GAAP basis

$     69,472

$     68,826

Stock-based compensation expense

(27,190)

(27,456)

General and administrative expense on a non-GAAP basis

$     42,282

$     41,370

Operating expense on a GAAP basis

$    388,912

$    351,487

Stock-based compensation expense

(103,347)

(97,726)

Amortization of purchased intangibles

(2,331)

(2,795)

Operating expense on a non-GAAP basis

$    283,234

$    250,966

Operating income on a GAAP basis

$    273,112

$    233,732

Stock-based compensation expense

119,259

112,210

Amortization of purchased intangibles

3,005

3,941

Operating income on a non-GAAP basis

$    395,376

$    349,883

Operating margin on a GAAP basis

30.9 %

30.8 %

Stock-based compensation expense

13.5

14.8

Amortization of purchased intangibles

0.4

0.5

Operating margin on a non-GAAP basis

44.8 %

46.1 %

Net income on a GAAP basis

$    260,936

$    228,190

Stock-based compensation expense

119,259

112,210

Amortization of purchased intangibles

3,005

3,941

Income tax effect on non-GAAP adjustments(6)

(12,063)

(16,513)

Net income on a non-GAAP basis

$   371,137

$   327,828

Diluted net income per share on a GAAP basis

$        1.57

$        1.37

Stock-based compensation expense

0.72

0.68

Amortization of purchased intangibles

0.02

0.02

Income tax effect on non-GAAP adjustments(6)

(0.07)

(0.10)

Diluted net income per share on a non-GAAP basis

$        2.24

$        1.97

________________________

(6)

For the three months ended April 30, 2026 and 2025, management used an estimated annual effective non-GAAP tax rate of 21.0%.

View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-fiscal-2027-first-quarter-results-302790659.html

SOURCE Veeva Systems

Continue Reading

Technology

Revolune and Concept Life Sciences Partner to Help Customers Transition Multiplex IF Assays to Flexible New Workflows

Published

on

By

OBERKOCHEN, Germany, Oct. 27, 2026 /PRNewswire/ — Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and scale multiplex immunofluorescence assays using Revolune’s flexible staining technology, which now supports 4- to 7-plex assays. 

The collaboration addresses a growing market need as customers evaluate alternatives to existing workflows and reconsider how best to support tissue biomarker research. With Revolune now offering 4- to 7-plex assay capabilities, Concept Life Sciences can help customers transfer established assays onto the Revolune platform, preserve valuable panel know-how, and move more easily from existing workflows to flexible, ready-to-use multiplex formats. 

“Many customers are not starting from a blank page — they already have assays, panels, and tissue biomarker strategies they need to preserve while moving toward more flexible workflows,” said Adrian Arechiga, CCO of Revolune. “Concept Life Sciences brings the translational biology, biomarker, and assay development expertise needed to help customers make that transition practically and confidently.” 

Concept Life Sciences is a leading contract research organization serving the global life sciences industry, with capabilities across discovery, development, analytical services, translational biology, biomarker discovery, spatial biology, and end-to-end chemistry. By combining these capabilities with Revolune’s adaptable multiplex immunofluorescence technology, the companies aim to help customers generate decision-ready tissue biomarker insights while reducing the operational burden of assay transfer and implementation. 

The partnership is designed for research teams that want to retain the scientific value of existing workflows while gaining access to a more flexible platform for multiplex staining. Customers can work with Concept Life Sciences to evaluate assay transfer feasibility, optimize panel design, run tissue staining workflows, and connect resulting biomarker data to broader discovery and development programs. 

“We are excited to work with Revolune to support customers who are rethinking how they approach multiplex tissue analysis,” said Adam Davenport, CSO at Concept Life Sciences. “Together, we can help teams transfer existing assays, explore new panels, and apply multiplex immunofluorescence in ways that support meaningful translational decisions.” 

The Concept Life Sciences partnership forms part of Revolune’s broader strategy to build an ecosystem of partners that support adoption across different customer needs — from specialist service execution to assay migration, translational biology, and integrated R&D support.

Meet Revolune and Concept Life Sciences at SITC 2026

Revolune and Concept Life Sciences will both be attending the Society for Immunotherapy of Cancer (SITC) Annual Meeting, November 4–8, 2026, in Phoenix, Arizona. 

Meet both teams at SITC at Sundown, a relaxed evening of complimentary drinks, dinner and conversation hosted by Concept Life Sciences on November 6, 6.30-8.30 pm. More information: https://www.conceptlifesciences.com/campaigns/sitc-2026.

About Revolune

Revolune is a life science company dedicated to making multiplex immunofluorescence as accessible and practical as routine tissue analysis. Its reagent technologies help laboratories move rapidly from existing primary antibodies to ready-to-use multiplex kits, simplifying spatial biology workflows and enabling researchers to focus on biological questions rather than assay management. 

About Concept Life Sciences

Concept Life Sciences is a leading contract research organisation (CRO) serving the global life sciences industry. For over 25 years, the company, and its heritage companies, have provided consultative and collaborative drug discovery and development services. Our approach, supported by passionate scientists and world-leading capabilities, enables clients to overcome complex scientific challenges and improves program success rates. The company has successfully helped 29 candidates advance to the clinic.

The company offers sophisticated translational biology services coupled with exceptional end-to-end chemistry capabilities to support drug discovery and development across a range of established and emerging modalities, with the ability to seamlessly integrate capabilities and provide bespoke solutions to address client needs.

Collectively, the company’s high-quality services and commitment to customer service across the drug development pathway enhances efficiency in drug discovery, helping clients advance their drugs to clinic in as little as 32 months, well ahead of the industry average of 60 months.

View original content to download multimedia:https://www.prnewswire.com/news-releases/revolune-and-concept-life-sciences-partner-to-help-customers-transition-multiplex-if-assays-to-flexible-new-workflows-302919466.html

SOURCE Revolune

Continue Reading

Technology

From Global Orders to Global Growth: Financial Infrastructure for Mid-Market Exporters

Published

on

By

At the 140th Canton Fair, PhotonPay demonstrates how its stablecoin-centric financial operating system helps growing exporters manage cross-border collections, currency conversion and global payments.

HONG KONG, Oct. 27, 2026 /PRNewswire/ — For a growing homewares exporter, a major overseas order brings opportunity, but also an immediate question: how will the business finance production, cover shipping costs and manage cash until the buyer pays?

A furniture manufacturer may need to pay suppliers weeks or months before receiving the final payment. A home décor or festive-goods exporter may be managing several seasonal orders at once, each with different delivery schedules, payment terms and currencies. As the business expands into more markets, tracking incoming payments, converting currencies and paying suppliers becomes increasingly complex.

These are everyday challenges behind international trade. At the second phase of the 140th Canton Fair, themed “Quality Home Life” and featuring furniture, kitchenware, household items, home decorations, gifts and festive products, PhotonPay is highlighting how financial infrastructure can help growing exporters manage these demands as they expand internationally.

Financial Tools for the Next Stage of Growth

Large multinational companies can draw on dedicated treasury teams, established banking relationships and sophisticated systems to manage funds across markets. Smaller businesses may have simpler payment needs. Mid-market exporters occupy a different position: their operations span multiple countries and currencies, while their finance teams often remain lean.

At the same time, production and freight costs must be covered before all customer payments arrive. Receivables may be spread across currencies and accounts, while suppliers expect payment according to their own schedules. Finance teams must track receipts, reconcile invoices and maintain a clear view of available funds.

Across multiple markets and overlapping orders, these tasks can consume significant time and complicate decisions about when and where to deploy cash. Growing exporters need practical tools to coordinate collections, manage funds across currencies and pay counterparties worldwide, without having to build a large treasury function from scratch.

Connecting Fiat and Stablecoin Rails to Global Business

Bank accounts and fiat payment networks remain central to international trade, connecting businesses to local collection methods and established banking relationships. Stablecoins offer an additional way to transfer value across borders, with transactions possible outside conventional banking hours depending on the network and transaction arrangements.

Connecting fiat and stablecoin rails can give businesses more flexibility in managing cross-border funds. For exporters, the practical value lies in connecting the stages of a cross-border financial workflow: receiving customer payments, converting currencies and making funds available for supplier payments and other business expenses.

PhotonPay is built around this connection. As a stablecoin-centric financial operating system, PhotonPay brings together a cross-border financial infrastructure across both fiat and stablecoin rails.

Its multi-asset wallet supports fiat currencies and stablecoins within a unified environment. Local collection capabilities cover 21 currencies, enabling businesses to receive payments in the currencies their customers use. Through integrated on- and off-ramp services, businesses can convert between fiat and stablecoins, while 24/7 foreign exchange allow funds to move across markets at any time. Cross-border payouts in fiat and stablecoins are available across 200+ countries and territories. Card issuing capabilities also allow companies to manage overseas business spending directly from one platform.

These capabilities connect the key stages of cross-border financial operations, and for growing exporters, this provides a more integrated way to manage international payments as their business expands.

PhotonPay also extends its infrastructure to platforms through Embedded Finance. Its APIs enable B2B platforms, marketplaces and other digital businesses to integrate financial capabilities, including accounts, fiat and stablecoin wallets, global payouts and card issuing, into their own products. This allows platforms to build collection, payment and fund management services into existing workflows and extend financial capabilities to their customers.

Financial Infrastructure That Grows With the Business

For mid-market exporters, international growth brings new customers, more markets and greater demands on financial operations. The ability to manage funds across borders needs to keep pace, supporting everything from the next production run to the next supplier payment and the next market entry.

By connecting fiat and stablecoin rails within one financial operating system, PhotonPay helps growing businesses manage cross-border funds with greater flexibility as they scale internationally.

Visit PhotonPay at Area D, Booths DT1714–DT1718, during the 140th Canton Fair.

About PhotonPay

PhotonPay is a stablecoin-powered payment operating system built for global infrastructure. Designed for modern enterprises, PhotonPay enables businesses to send, receive, convert, and settle funds across both fiat and stablecoin rails through a single, compliance-first integration, spanning 200+ countries and territories.

For more information, visit [www.photonpay.com].

Disclaimer

This material is for general informational purposes only and does not constitute legal, regulatory, tax, accounting, or investment advice, nor an offer or solicitation for any product or service. The availability, features, and regulatory treatment of PhotonPay’s products and services may vary depending on the user’s location, business model, and the laws and regulations that apply. Any descriptions of functionality, performance, efficiency, cost savings, or compliance support (including, without limitation, references to “real‑time”, “24/7”, “high‑efficiency”, or “compliant” solutions) are aspirational or forward‑looking in nature. Actual outcomes may differ due to market conditions, technological constraints, and regulatory developments, and PhotonPay makes no express or implied representation, warranty, or guarantee as to the achievement of any particular result.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/from-global-orders-to-global-growth-financial-infrastructure-for-mid-market-exporters-302920151.html

SOURCE PhotonPay

Continue Reading

Technology

Rockwell Automation Unveils Record-Breaking Innovation Lineup at Automation Fair 2026

Published

on

By

From AI-powered manufacturing and next-generation control to cybersecurity and digital engineering, Rockwell showcases technologies designed to help manufacturers build the future of industrial operations

MILWAUKEE, Oct. 27, 2026 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced an expanded product showcase for Automation Fair® 2026. Across the plant floor and enterprise, Rockwell’s latest innovations help manufacturers unlock greater productivity, simplify operations and strengthen resilience in an increasingly complex industrial environment. Together, these technologies demonstrate how AI, automation and digital transformation are reshaping the future of industrial operations.

At Automation Fair 2026, attendees will get an exclusive look at new technologies designed to help manufacturers modernize production, accelerate decision-making and scale innovation with greater confidence. The innovations span Rockwell’s automation and software portfolio showcasing practical applications that address some of the industry’s most pressing operational challenges.

“Production systems today are balancing growth, workforce challenges, cybersecurity threats and the need to adapt faster than ever before,” said Matheus Bulho, senior vice president, software & control, Rockwell Automation. “At Automation Fair 2026, we’re bringing together hardware, software and industrial intelligence in new ways, giving customers the tools to move faster, adapt with confidence and create more resilient and autonomous operations.”

Among the list of record-breaking innovative new technologies being showcased are:

LogixEdge™ Controller, enhancing the power of Logix with new form factors and seamless integration of IT and OT workloads that further amplify Logix’s powerful multidiscipline control and information capabilities, including AI workloads that enable autonomous controlCompactLogix® 5390 Controller, delivering enhanced performance and security with greater scalability for modern production system environments.PointMax™ I/O, a next-generation I/O platform designed to simplify deployment and support high-performance machine applications.Armor™ PowerFlex® 330 Integrated Drive Motor, combining motor and drive functionality in a compact solution to reduce complexity and accelerate installation.EtherNet/IP™ In-cabinet Solution, helping manufacturers simplify what it takes to construct, wire, deploy and manage industrial control systems more efficiently.FactoryTalk® Optix™ Version 1.9 and new OptixPanel™ Pro and PanelView™ Pro graphic terminals, providing expanded visualization capabilities across larger distributed systems, enhanced security and a modern operator experience.FactoryTalk® Conductor™, enabling organizations to orchestrate industrial intelligence and agentic engineering across design, operations and maintenance for their entire operations.FactoryTalk® AssetIQ™, FactoryTalk® Design Workbench™ and FactoryTalk® ResilientEdge™ software, helping customers simplify enterprise OT asset management, streamline engineering and improve resilience of edge deployments.New AI innovations for the Plex Smart Manufacturing Platform™ and AI-powered Quality Management capabilities, bringing practical artificial intelligence to everyday manufacturing workflows.Expanded cybersecurity offerings, including SecureOT™ Platform Managed Services, OT Cybersecurity Assessment Suite, and capabilities designed to support OEMs in building more secure machines from the start

In addition to product announcements, attendees will have the opportunity to experience live demonstrations, engage with Rockwell Automation experts and partners and explore the innovations driving greater productivity, flexibility and resilience across manufacturing.

Registration is now open. Join thousands of industrial professionals at Automation Fair 2026 and be among the first to experience Rockwell’s latest innovations in action. Register today at automationfair.com.

About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-automation-unveils-record-breaking-innovation-lineup-at-automation-fair-2026-302907266.html

SOURCE Rockwell Automation, Inc.

Continue Reading

Trending